<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmaceutical sciences / Pharmaceuticals policy / Clinical research / Medical equipment / Electronic health record / Medical device / Validation / Center for Devices and Radiological Health / Medicine / Food and Drug Administration / Health
Date: 2011-06-02 10:13:05
Pharmaceutical industry
Pharmaceutical sciences
Pharmaceuticals policy
Clinical research
Medical equipment
Electronic health record
Medical device
Validation
Center for Devices and Radiological Health
Medicine
Food and Drug Administration
Health

Analysis New FDA Rule May Affect Healthcare Facilities Using Customized Health IT Systems By Michele L. Buenafe, Morgan Lewis & Bockius, LLP, Washington, DC Hospitals and other healthcare facilities that utilize customi

Add to Reading List

Source URL: www.morganlewis.com

Download Document from Source Website

File Size: 2,90 MB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document